Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1993-11-30
1997-04-01
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 53, 536 172, 536 187, 536 55, 536 551, 536 553, 5361231, A61K 31715, C07H 100, C07H 504, C07H 506
Patent
active
056165684
ABSTRACT:
Hyaluronate functionalized with dihydrazide is provided and may be cross-linked. A method for producing hyaluronate functionalized with dihydrazide includes mixing hyaluronate and dihydrazide in aqueous solution, then adding carbodiimide so that the hyaluronate and dihydrazide react to form functionalized hyaluronate.
REFERENCES:
patent: 3798199 (1974-03-01), Han
patent: 4500676 (1985-02-01), Balazs et al.
patent: 4582865 (1986-04-01), Balazs et al.
patent: 4636524 (1987-01-01), Balazs et al.
patent: 4713448 (1987-12-01), Leshchiner et al.
patent: 4736024 (1988-04-01), Della et al.
patent: 4937270 (1990-06-01), Hamilton et al.
patent: 4957444 (1990-09-01), Della Valle et al.
patent: 5017229 (1991-05-01), Burns et al.
T. Pouyani, et al., "Solid-State NMR of N-Acylureas Derived From the Reaction of Hyaluronic Acid With Isotopically-Labeled Carbodiimides," J. Am. Chem. Soc. 114, 5972-5976 (1992).
E. Ghezzo, et al., "Hyaluronane Derivative Microspheres As NGF Delivery Devices: Preparation Methods and in Vitro Release Characterization", International Journal of Pharmaceutics 87, 21-29 (1992).
H. N. Joshi, et al., "Drug Release From Membranes of Hyaluronic Acid and Its Esters", Journal of Controlled Release 20, 109-122 (1992).
N. Yui, et al., "Inflammation Responsive Degradation of Crosslinked Hyaluronic Acid Gels", Journal of Controlled Release 22, 105-116 (1992).
D. Swann et al., "Hyaluronic Acid", in Biomaterials, Novel Materials From Biological Sources, D. Byrom, ed., Stockton Press 1991, 287-305.
L. M. Benedetti, et al., "Microspheres of Hyaluronic Acid Esters-Fabrication Methods, and In Vitro Hydrocortisone Release", Journal of Controlled Release 13, 33-41 (1990).
J. A. Hunt, et al., "Diffusion and Drug Release in Polymer Films Prepared From Ester Derivatives of Hyaluronic Acid", Journal of Controlled Release 12, 159-169 (1990).
J. Kopecek, "The Potential of Water-Soluble Polymeric Carriers in Targeted and Site-Specific Drug Delivery", Journal of Controlled Release 11, 279-290 (1990).
L. B. Dahl, et al., "Preparation of Biologically Intact Radioiodinated Hyaluronan of High Specific Radioactivity: Coupling of .sup.125 I-Tyramine-Cellobiose to Amino Groups After Partial N-Deacetylation", Analytical Biochemistry 175, 397-407 (1988).
T. C. Laurent, et al., "Cross-linked Gels of Hyaluronic Acid", Acta Chem. Scand. 18, 274-275 (1964).
Pouyani Tara
Prestwich Glenn D.
Lee Howard C.
Robinson Douglas W.
The Research Foundation of State University of New York
LandOfFree
Functionalized derivatives of hyaluronic acid does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Functionalized derivatives of hyaluronic acid, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Functionalized derivatives of hyaluronic acid will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-538962